Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same author

Platelet-derived vesicles restore fertility in endometrial injury by modulating the endometrial immune niche in mice.

Science advances·2026
Same author

Scaffolds toughen bacteria-based therapy.

Science (New York, N.Y.)·2026
Same author

Engineering Microbial Particles for Next-Generation Biomedical Platforms.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation.

Bioconjugate chemistry·2026
Same author

Attenuating age-related decline in dendritic cell migration improves vaccine efficacy via gut-immune crosstalk.

Nature aging·2026
Same journal

Chlorinated VSLSs Surpass HCFCs in CFC-11-Equivalent Emissions for Ozone Layer Depletion in China.

Nature communications·2026
Same journal

Author Correction: Charge transfer in triphenylamine-tetrazine covalent organic frameworks for solar-driven hydrogen peroxide production.

Nature communications·2026
Same journal

Vegetation browning patterns under compound soil and atmospheric dryness in northern permafrost ecosystems.

Nature communications·2026
Same journal

Voltage imaging of CA1 pyramidal cells and SST+ interneurons reveals stability and plasticity mechanisms of spatial firing.

Nature communications·2026
Same journal

Radical-omics reveals the hydrogen-abstraction pathway of isoprene oxidation.

Nature communications·2026
Same journal

Toughening elastomer via sequentially activated multi-pathway energy dissipation.

Nature communications·2026
See all related articles

Related Experiment Video

Updated: Mar 29, 2026

Generation of Scalable, Metallic High-Aspect Ratio Nanocomposites in a Biological Liquid Medium
13:34

Generation of Scalable, Metallic High-Aspect Ratio Nanocomposites in a Biological Liquid Medium

Published on: July 8, 2015

9.6K

Transformable liquid-metal nanomedicine.

Yue Lu1,2, Quanyin Hu1,2, Yiliang Lin3

  • 1Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina 27695, USA.

Nature Communications
|December 3, 2015
PubMed
Summary
This summary is machine-generated.

A novel liquid-metal nanomedicine offers a biodegradable and low-toxicity alternative for drug delivery. This transformable nanocarrier fuses and degrades in acidic conditions, enhancing chemotherapy efficacy in tumors.

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.6K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.1K

Related Experiment Videos

Last Updated: Mar 29, 2026

Generation of Scalable, Metallic High-Aspect Ratio Nanocomposites in a Biological Liquid Medium
13:34

Generation of Scalable, Metallic High-Aspect Ratio Nanocomposites in a Biological Liquid Medium

Published on: July 8, 2015

9.6K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.6K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.1K

Area of Science:

  • Materials Science
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Inorganic nanocarriers for drug delivery systems (DDSs) face challenges with toxicity and biodegradability.
  • Developing safe and effective nanomedicines is crucial for clinical applications.

Purpose of the Study:

  • To develop a transformable liquid-metal nanomedicine with enhanced drug delivery capabilities.
  • To address the limitations of traditional inorganic nanocarriers.

Main Methods:

  • Fabrication of core-shell nanospheres using a liquid-phase eutectic gallium-indium core and a thiolated polymeric shell via sonication.
  • Loading nanoparticles with doxorubicin (Dox) and functionalizing with hyaluronic acid for tumor targeting.
  • Evaluating nanoparticle fusion, degradation under acidic conditions, and in vivo efficacy in xenograft tumor-bearing mice.

Main Results:

  • The liquid-metal nanoparticles (average diameter 107 nm) demonstrated fusion and degradation in mildly acidic environments.
  • Doxorubicin release was facilitated in acidic endosomes post-cellular internalization.
  • Hyaluronic acid conjugation enhanced chemotherapeutic inhibition in tumor models.
  • The nanomedicine exhibited low toxicity.

Conclusions:

  • A novel liquid metal-based DDS was engineered with fusible and degradable properties.
  • This formulation presents a promising strategy for developing low-toxicity theranostic agents.
  • The developed nanomedicine shows potential for improved cancer chemotherapy.